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Introduction 
Stroke is the third leading cause of death in North America and Europe (Reiter et al., 
2005).  Every year about 600,000 people in America suffer from a new or recurrent stroke.  
Currently, there are over three million Americans permanently disabled because of stroke (White 
et al., 2000).  There are two different types of stroke: ischemic and hemorrhagic.  The present 
study focuses on ischemic stroke, the better understood of the two.  An ischemic stroke occurs 
when the oxygen to the brain is cut off due to the blocking of a blood vessel located within the 
brain, which in turn leads to neuronal death (Stahl, 1997).  Stroke affects 12 common domains 
including energy, family roles, language, mobility, mood, personality, self-care, social roles, 
thinking, upper extremity function, vision, and work/productivity.  Among these domains 
hand/arm function, family roles, and language have been reported to be the most affected 
compared to the others (Williams et al., 1999). 
During ischemia, the neurons comprising the core infarct, which receive no oxygen at all, 
suffer the most damage.  Surrounding the core, the neurons in the ischemic penumbra, receive 
some oxygenated blood and thus suffer less damage (Reiter et al., 2005).  There are two modes 
of cell death during ischemia: necrosis and apoptosis.  Membrane dysfunction and cell swelling 
characterize necrosis (Stoll et al., 1998).  The neurons of the ischemic core undergo rapid 
necrotic cell death due to a reduction in adenosine triphosphate (ATP) that leads to an increase in 
neuronal cytosolic Ca2+ concentration.  The influx of Ca2+, via pump failure and depolarization, 
sets off a chain of events that primes the brain to more damage during reperfusion (White et al., 
2000).   Apoptosis, programmed cell death, occurs after the onset of reperfusion peaking at 24-48 
h post-reperfusion (Stoll et al., 1998).  Also contributing to reperfusion injury is inflammation 
attributed to the activation of cytokines, inducible nitric oxide synthase (iNOS), and intracellular 
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adhesion molecule 1 (ICAM-1) (Turley et al., 2005).  The current study focuses on the effects of 
neonatal LPS exposure on the development of post-ischemic infarct development.   
When an animal is exposed to an inflammagen, such as lipopolysaccharide (LPS), a 
component of the outer membrane of Gram-negative bacteria, its immune system responds by 
initiating an immune response.  Specifically, when exposed to LPS, immune cells synthesize 
cytokines that induce COX-2 to synthesize prostaglandin E2 (PGE2) within the central nervous 
system (CNS) (Boissé et al., 2004).  PGE2, by way of inflammation, contributes significantly to 
the outcome after ischemic insult (Yrjänheikki et al., 1999); elevated PGE2 increases infarct size, 
while attenuated PGE2 decreases infarct size (Nogawa et al., 1997). The induction of COX-2 has 
long-term effects: administration of Escherichia coli LPS to neonate rats raised their basal levels 
of COX-2 expression as adults compared to adult rats neonatally administered a pyrogen-free 
saline (Boissé et al., 2004).  The basal level of COX-2 is strongly correlated with the level of 
PGE2 generation, the rate-limiting enzyme of PGE2 synthesis (Nogawa et al., 1997).  Therefore, 
when exposed to an LPS, an increase in the basal level of COX-2 will result in an increase in the 
level of PGE2 response (Boissé et al., 2004). 
COX-2 plays a role in both the early and late stages of cerebral ischemia.  Immediately 
after the induction of ischemia, the activation of glutamate receptors by COX-2 initiates the 
ischemic cascade, contributing to damage occurring in the early stages of stroke (Iadecola et al., 
2001).  Indeed, suppressing COX-2 expression decreases ischemic damage. For example, COX-2 
null mice have significantly less neuronal damage following experimental stroke relative to their 
wild-type littermates in both 24 h post-ischemic and 96 h post-ischemic assessments (Iadecola et 
al., 2001).   
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The goal of the current study was to examine the effects of early life infection on adult 
ischemic outcome.  It was hypothesized that administering LPS as a neonate would increase the 
size of the stroke-induced infarct as an adult compared to that of an adult administered a 
pyrogen-free saline solution as a neonate via the up-regulation of the COX-2 enzyme, and it’s 
effects, in turn on PGE2 expression. 
 
Methods 
Animals 
Male and female C57BL/6 mice (Charles River, Wilmington, MD, USA) were paired and 
maintained in a temperature controlled (21˚C) vivarium on a 14:10 light/dark cycle, with ad 
libitum access to food and water.  On post-pairing day 15, the males were separated from the 
pregnant females.  All subsequent litters were weaned at 21 d, and males and females housed 
separately <6 per cage until they reached 22-25 g.  The study was conducted in accordance with 
NIH guidelines for the care and use of animals and under protocols approved by the Institutional 
Animal Care and Use Committee. 
 
Study 1 
Early life manipulations: Neonatal treatment for longitudinal study 
On postnatal day 14 (P14) litters were randomly selected and Escherichia coli LPS (Product 
Number L 2654) was administered intraperitoneally in pyrogen-free sterile saline (1µl/g pup 
weight) at a dose of 50µg.  The other litters were administered an equivalent amount of sterile, 
pyrogen-free saline.   
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Surgery 
Transient focal cerebral ischemia was induced in the mice by middle cerebral artery occlusion 
(MCAO).  The mice were anesthetized with 1-1.5% halothane in oxygen-enriched air delivered 
through a facemask.  Occlusion of the right middle cerebral artery was achieved by using the 
intraluminal filament insertion technique.  A 6-0 nylon monofilament was inserted into the 
internal carotid artery, via the external carotid artery.  Then the filament tip (approximately 1.0 
mm length and 0.25 mm width) was positioned for occlusion at a distance of 6 mm beyond the 
internal carotid artery-pterygopalatine artery bifurcation.  Once the filament was secured, the 
incision was sutured, and the animal was allowed to emerge from the anesthesia in its home 
cage.  After 60 min of occlusion, the animal was briefly re-anesthetized with halothane in 
oxygen-enriched air, and reperfusion was initiated via withdrawal of the filament.  This surgery 
protocol typically results in a core infarct limited to the parietal cerebral cortex and caudate 
putamen of the right hemisphere.   For the sham MCAO surgery, the internal carotid artery was 
exposed but not disturbed.  All other aspects of the surgery were similar for the MCAO and sham 
MCAO groups.  Throughout the surgery, rectal temperature was maintained at 37±0.5˚C through 
the use of a homoeothermic blanket system.  All animals were given a 0.5 ml s.c. injection of 
lactated Ringer’s solution at the conclusion of the surgical procedure, and returned to their home 
cage for recovery. 
 
Determination of stroke volume 
Immediately following cervical dislocation, brains were removed, placed in a -70ºC freezer for 2 
min, and then sectioned into five 2-mm-thick coronal sections.  Sections were incubated for 15 
min in 2,3,5-triphenyltetrazolium (TTC), with rotation every 2 min to allow uniform tissue 
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staining.  The TTC solution was maintained at 37ºC throughout the staining process.  Following 
staining, the sections were fixed in 10% buffered formalin solution.  The brain slices were 
photographed and measured using Inquiry software (Loats Associates Inc., Westminster, MD, 
USA).  The images were used to determine infarct size as a percentage of the contralateral 
hemisphere after correcting for edema.  Comparisons between infarct sizes via TTC will account 
for the secondary damage attributed to stroke. 
 
Determination of Post-Stroke Edema 
To determine post-stroke edema following 60 min MCAO mice, brain tissue was collected at 24 
h reperfusion immediately following transcardial perfusion with 20 ml saline.  The brain tissue 
was immediately divided into right (ischemic) and left (non-ischemic) hemispheres and weighed.  
The tissue was then dried at 70ºC for 72 h.  Once fully dehydrated, an index of edema was 
calculated using the following equation: 1 = (W/DR – W/DL)/(W/DL) x 100.   
 
Behavioral testing  
Behavior will be assessed at 24 h pre-induction of experimental stroke and at either 24 h or 72 h 
post-stroke, depending on whether the initial infarct damage or the secondary damage will be 
assessed.  
Cylinder Test: This test evaluates exploratory behaviors and paw preference.  A clear Plexiglas 
cylinder (8 cm internal diameter, 12 cm height) was placed horizontally on a clean surface, and 
centered among four cameras to allow simultaneous viewing of the animal from all angles. The 
mouse was placed inside the cylinder and videotaped for five minutes.  Initial placement of the 
left versus right paw on the cylinder was recorded during rearing to assess preferential paw use 
 6
(adapted from Karhunen et al., 2003).  Only the first paw placement is recorded for each rear.  
Paw preference data are presented as frequency of left paw placement/total rearing frequency.  A 
decrease in left (contralateral) paw use suggests a functionally significant impairment of the right 
sensorimotor cortex.  Paw preference was determined using the following formula: 
[left/(left+right+simultaneous)]x100. 
Locomotor activity: General locomotor activity was assessed during a 60 min session.  The 
locomotor apparatuses were enclosed in individual sound attenuating chambers equipped with a 
15-W fluorescent white light and a ventilation fan.  The monitors consisted of a clear 60 cm wide 
x 60 cm long acrylic box that was cleaned between trials and placed in a metal frame that was 
lined with 16 equally spaced photo beams along two sides of the box.  Four intervals of 900 s 
each recorded the movement of each mouse testing inclination to stay close to the walls of the 
chamber or venture into the center.  The locomotor chamber serves as an anxiety paradigm; 
staying close to the walls representing anxious behavior and venturing into the center 
representing less anxious and more exploratory behavior.  This test also counts for total rearing.  
Total distance traveled (cm) was determined using PAS software (San Diego Instruments, San 
Diego, CA). 
 
Statistical Analysis 
Infarct data was compared among experimental conditions using one way analysis of variance 
(ANOVA).  Behavioral data was compared using ANOVA with repeated measurement factor for 
behavior (pre vs. post).  Relative growth data was compared using both ANOVA with repeated 
measurement factor for postnatal day and also using one way ANOVA for final weights.   
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Results 
Adult mice neonatally exposed to LPS show no significant difference in 24 h edema  
There was no significant difference in edema between female adults neonatally treated with LPS 
(n=4) and female adults neonatally treated with saline (n=4; p>0.05) (Fig. 1).  Similarly there 
was no significant difference in edema between male adults neonatally treated with LPS (n=5) 
and male adults neonatally treated with saline (n=5;p>0.05) (Fig. 2).    These results suggest that 
early exposure to LPS has no effect on brain water content in response to inflammation 
following a stroke. 
 
No effect of LPS on locomotor activity 24 h post-ischemia 
There was no significant difference in any components of the locomotor activity for adult 
females neonatally exposed to LPS (n=4) compared to the vehicle females (n=4;p>0.05 for all).  
Similarly there was no significant difference in any components of the locomotor activity for 
adult males neonatally exposed to LPS (n=5) compared to the vehicle males (n=5;p>0.05 for all).  
The power in both groups was very low indicating that there is a large amount of variability in 
the data.  An increase in n may provide more sufficient results. 
 
Cylinder test shows no significant difference in adults neonatally exposed to LPS 24 h post-
ischemia 
There was no significant difference in paw use post-ischemia compared to paw use pre-ischemia 
in adult mice neonatally exposed to LPS compared to the vehicle in males (p>0.05) or females 
(p>0.05).  Both statistical comparisons suffered from low power due to high variability, thus the 
null hypothesis is cautiously accepted.  
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72 h infarct analysis shows that adult females neonatally exposed to LPS are 
neuroprotected compared to vehicle and to male counterpart 
There was a significant decrease in secondary infarct size in female adults neonatally treated 
with LPS (n=9) compared to female adults neonatally treated with saline (n=7; 
(F(1,14)=4.947;p<0.05) (Fig. 3).  In contrast, there was no significant difference in infarct size 
between male adults neonatally treated with LPS (n=13) and male adults neonatally treated with 
saline (n=11;p>0.05) (Fig. 4).  A correlation between LPS exposure and a decrease in infarct size 
is shown in the male study, but experimental power was very low, which decreases the certainty 
with which the null hypothesis is accepted.  Taken together, these data suggest that early 
exposure to LPS is acting as a neuroprotective agent against ischemia in adulthood in female, but 
possibly not male, mice.   
 
Effect of LPS on locomotor activity 72 h post-ischemia 
Females 
There was no effect on any components of the locomotor test pre-surgery (p>0.05 for all).  
Females treated with LPS MCAO (n=9) show a significant decrease in rearing compared to 
females treated with LPS sham (n=3;F(2,16)=4.822;p<0.05).  Female vehicle MCAO (n=7) also 
show a significant decrease in rearing compared to females treated with LPS sham 
(n=3;F(2,16)=4.822;p<0.05).  There was no effect of LPS on any other component of locomotor 
activity for females.   
Males 
There was a significant decrease in peripheral movement pre-surgery for LPS (n=13) compared 
to vehicle (n=14;F(1,25)=4.997;p<0.05).  There was not, however, any significant effect post-
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surgery (p>0.05).  There was no effect pre- or post-surgery for central locomotor activity, central 
+ peripheral locomotor activity, or percent of total activity spent in the center (p>0.05 for all).  
There was an overall effect of experimental groups for rearing post-surgery 
(F(3,23)=9.853;p<0.05).  Post hoc analysis reveals a significant decrease in LPS MCAO (n=9) 
compared to LPS sham (n=4; F(1,11)=17.630;p<0.05).  There is also a significant decrease in 
rearing in vehicle MCAO (n=11) compared to LPS sham (n=4;F(1,13)=19.161;p<0.05) and a 
significant decrease in vehicle MCAO (n=11) compared to vehicle sham 
(n=3;F(1,12)=4.212;p<0.05).  These results suggest that rearing decreases following MCAO, but 
is not affected by LPS treatment.  
 
Cylinder test, 72 h post-surgery, shows severe damage provided by LPS treatment despite 
neuroprotective capabilities 
Females treated with LPS MCAO (n=9) show a significant decrease in contralateral paw use 
compared to the vehicle MCAO (n=7;F(2,16)=6.319;p<0.05).  Females treated with LPS MCAO 
also show a significant decrease in contralateral paw use compared to females treated with LPS 
sham (n=3;F(2,16)=6.319;p<0.05) (Fig. 5).  These results suggest a significant effect of MCAO 
and LPS on paw preference.  There was no significant difference in the paw preference in male 
adults neonatally treated with LPS (n=8) compared to male adults treated neonatally with saline 
(n=10;p>0.05) (Fig. 6).  There was also no significant difference in paw preference in males 
treated with LPS MCAO compared to males treated with LPS sham (n=5;p>0.05), nor was there 
a significant difference in paw preference in male vehicle MCAO compared to male vehicle 
sham (n=3;p>0.05). 
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No difference in growth between mice neonatally exposed to LPS compared to vehicle 
There was no significant difference in relative growth rate between female mice neonatally 
exposed to LPS (n=24) compared to their vehicle counterpart (n=16;p>0.05).  There was also no 
significant difference in relative growth rates between male mice neonatally exposed to LPS 
(n=18) compared to the vehicle in males (n=17; p>0.05).  These results suggest that neonatal 
infection does not influence mouse growth rate. 
 
Study 2 
This study is a repeat of the first differing only in the concentration of LPS administered. 
On postnatal day 14 (P14) litters were randomly selected and Escherichia coli LPS (Product 
Number L 2654) was administered intraperitoneally in sterile saline (1µl/g pup weight) at a dose 
of 100µg.  The other litters were administered an equal amount of sterile, pyrogen-free saline.  
All other methods are exactly as written above. 
 
Results 
Adult mice neonatally exposed to LPS show no significant difference in 24 h edema  
Female mice neonatally exposed to LPS (n=2) show no significant difference in edema brain 
weight compared to the vehicle female (n=4; p>0.05).  The power is very low (<0.1) implying 
much variability suggesting that an increase in animal number may provide more significant 
results.  There are no results as of yet for male mice neonatally exposed to LPS.   
 
*Note: Due to an uneven ratio of male to female pups there were not enough males to assess any 
effects of stroke 24 h post-surgery. 
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 No effect of LPS on locomotor activity 24 h post ischemia  
There was no significant difference in locomotor activity 24 h post-ischemia for adult females 
neonatally exposed to LPS (n=2) compared to the vehicle females (n=5; p>0.05).  A low power 
indicates much variability. 
 
No effect of LPS on contralateral paw use 24 h  
There was no significant difference in the right versus left paw use 24 h post-ischemia in adult 
females neonatally exposed to LPS (n=2) compared to vehicle female (n=5; p>0.05).   
 
72 h infarct analysis shows that adult mice neonatally exposed to LPS show no significant 
difference in infarct size compared to vehicle 
Female adult mice neonatally exposed to LPS (n=6) showed no significant difference in infarct 
size compared to the vehicle female (n=6; p>0.05).  Similarly, male adult mice neonatally 
exposed to LPS (n=5) showed no significant difference in infarct size compared to the vehicle 
male (n=11; p>0.05).     
 
No effect of LPS on locomotor activity 72 h post ischemia 
There was no significant difference in locomotor activity 72 h post-ischemia for adult females 
neonatally exposed to LPS (n=6) compared to the vehicle females (n=6; p>0.05).  There was no 
significant difference in locomotor activity 72 h post-ischemia for adult males neonatally 
exposed to LPS (n=5) compared to the vehicle males MCAO (n=11; p>0.05).  Also there was no 
significant difference in locomotor activity 72 h post-ischemia for adult males neonatally 
exposed to LPS (n=5) compared to vehicle males sham (n=3;p>0.05).  . 
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No effect of LPS on contralateral paw use 72 h post-ischemia 
There was no significant difference in right versus left paw use 72 h post-ischemia in adult 
females neonatally exposed to LPS (n=5) compared to vehicle females (n=7: p>0.05).  There was 
no significant decrease in contralateral paw use in males treated with LPS (n=5) compared to 
male vehicles sham (n=3;p>0.05).  There was also no significant decrease in contralateral paw 
use in males treated with LPS (n=5) compared to male vehicles MCAO (n=7;p>0.05).   
 
Exposure to LPS as a neonate does effect animal growth  
Female mice neonatally exposed to LPS (n=16) show a significant difference in relative growth 
rate compared to the vehicle (n=16;F(1,30)=12.175;p<0.05).  Post hoc analysis reveals a 
significantly heavier weight in LPS females compared to vehicle at each 7 day interval from P14 
to P42 (p<0.05 for all) and a significantly lighter weight in LPS females compared to vehicle at 
P49 (p<0.05) (Fig. 7).  Male mice neonatally exposed to LPS (n=7) show no difference in 
relative growth rate compared to the vehicle (n=7) (Fig. 8). 
 
Discussion 
 In this study, we examined the effects that neonatal infection has on adult stroke outcome 
in mice.  Stroke damage was compared between mice that had been infected as neonates with 
LPS versus the vehicle control.   In females treated neonatally with low LPS there was a 
significant decrease in infarct size 72 h post-surgery.  These data suggest that a low dose of LPS 
is providing neuroprotection in females against ischemia in adulthood.  Contrary to these data, 
however, there was a significant decrease in contralateral paw use 72 h post-surgery in females 
treated with the low dose of LPS compared to vehicle.  This implies that although LPS is 
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preventing neuronal death, the damage to the neurons is such that behavioral deficits common 
following stroke still develop.  There was no effect on of LPS treatment in females on edema 24 
h post-behavior, nor was there any effect on locomotor or paw preference behavior 24 h post 
surgery.  One female was not included in the 72 h cylinder testing because the total post was 
greater than two times the standard deviation making the animal an outlier.   
The first study found no significant difference in the stroke outcome or behavior for male 
adults treated neonatally with LPS compared to vehicle, regardless of whether assessment was 
made 24 h post-surgery or 72 h post-surgery.  Future studies will employ a higher dose of LPS in 
males.  
To test for dose dependent differences, in the second study a higher dose of LPS was 
administered to the neonates.  The higher dose showed no effect of treatment on edema 24 h 
post-surgery and there was also no effect on infarct 72 h post-surgery.   This higher dose also 
showed no effect on behavior or anxiety in either of the assessments.  That there was no effect on 
72 h post-surgery mice treated with the higher dose of LPS leads us to believe that the dose was 
high enough to no longer provide neuroprotection yet not high enough to affect behavior in non-
ischemic mice.   
 The significant decrease in locomotor activity for both male and female 72 h post-MCAO 
surgery compared to 72 h post-sham surgery indicates an effect of surgical technique on mice 
treated with the low dose of LPS.  There was not, however, any effect of surgical technique on 
mice treated with the higher dose of LPS.    
There appears to be inconclusive, yet promising, data for the impact on up-regulated 
COX-2 in both initial and secondary ischemic pathways.  The next step is to increase each data 
set to reduce the variability, increase statistical power, and then to increase the dose of LPS 
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administered.  There is an apparent difference in results between the two doses suggesting the 
amount of LPS injected has a significant effect on stroke outcome.  Assessing the role of COX-2 
post-stroke will afford much information about the exact role that COX-2 plays and how it is 
comparatively up-regulated with each LPS dose.  Also assessing the level of PGE2 in the brain 
post-stroke will prove useful in identifying the level of COX-2 and its role in ischemia, as PGE2 
is a by-product of COX-2 and the inflammatory agent in secondary stroke outcome.  
Specifically, PGE2 EP1 receptors have been denoted the underlying factor in neurotoxicity, that 
in fact COX-2-derived PGE2 is not neurotoxic in the absence of EP1 (Kawano et al, 2006.   
Studies show that administration of an EP1 receptor inhibitor SC51089 reduces the infarct size in 
ischemic stroke (Kawano et al, 2006).  It would therefore be interesting to determine the effect 
LPS has on EP1 receptors.    
If administering a small amount of LPS as a neonate is neuroprotective to ischemia, it 
could prove to be a very important therapeutic agent in human stroke.  As an influenza 
vaccination protects against the influenza virus, perhaps the cell wall of a gram-negative bacteria 
will protect against stroke.  In recent years, COX-2 inhibitors have been associated with 
improved stroke outcome.  However, COX-2 inhibitors suppress vasodilators such as 
prostacyclin (PGI2) that counter the cardiovascular effects of the platelet agonist vasoconstrictor 
thromboxane (TxA2).  Thus inhibition of COX-2 may indirectly enhance the risk of thrombosis 
(Fitzgerald, 2003), and subsequently stroke or cardiac arrest.   It will be interesting to determine 
the relationship between LPS as a protective agent and the subsequent increase in COX-2 as a 
protective agent against stroke.   
 It is necessary to determine the role that COX-2 has in the mechanisms underlying stroke 
damage, as COX-2 may not be the only player.  Studies have shown that when exposed to LPS 
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iNOS can be induced to express in macrophage resulting in the production of large amounts of 
nitric oxide (NO) (Luo et al. 2005).  NO derived from activated macrophages strongly influences 
immune function through inhibiting cell proliferation, antibody production, and regulating 
cytokine production.  Therefore, one may speculate that exposure to LPS increases the level of 
NO produced in the system resulting in a larger infarct size post-stroke due to an attenuated 
immune response.  Perhaps a small amount of LPS inhibits nitric oxide attenuating the level of 
PGE2 concentration.    
 The present study has shown that a low dose LPS acts as a neuroprotective agent against 
ischemia in females.  Despite reduced neuronal death in low dose LPS females, behavioral 
deficits still developed, indicating that neurons were still damaged.  Also, because there was no 
effect on females with a high dose LPS it can be implied that the effects of LPS are dose-
dependent, and having no effect on males whatsoever, implies a gender-bias.  Future research 
will be aimed at determining the mechanism underlying the protective qualities of neonatal 
exposure to LPS in female mice. 
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Figure 1: No effect of LPS in female edema 
Mean ± SEM 
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Figure 2: No effect of LPS in male edema 
Mean ± SEM 
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Figure 3: Females treated with LPS show a reduction in infarct  
72 h post-surgery compared to vehicle 
Mean ± SEM 
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Figure 4: No effect of LPS on male infarct size 
72 h post-surgery compared to vehicle 
Mean ± SEM 
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Figure 5: Females treated with LPS show a reduction in contralateral paw use 
72 h post-surgery compared to vehicle 
Mean ± SEM 
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Figure 6: No effect of LPS on contralateral paw use 
72 h post-surgery 
Mean ± SEM  
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Figure 7: Females treated with high LPS were significantly  
heavier than vehicle from P21-P42, and significantly lighter on P49 
Mean ± SEM 
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Figure 8: No effect of LPS on growth 
Mean ± SEM 
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